March 1, 2011

Use of a Genomic Test (MammaPrint™) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients

Arch Gynecol Obstet (2011) 283: 597.

Kunz, G.

44 patients had MammaPrint results and were eligible for the analysis. The results revealed a low risk result in 29 patients and a high risk result in 15 patients.

Read more: Kunz_2011_Arch Gynecol Obstet._Use of a Genomic Test